Nanoparticle Therapeutics for Treating Skin Inflammatory Disorders

The present invention provides nanoparticles and methods for treating and preventing skin inflammatory conditions or disorders. The conditions or disorders include allergic contact dermatitis (ACD), irritant contact dermatitis, atopic dermatitis (AD), photoallergic dermatitis, and contact hypersensitivity (CHS), as well as other conditions or disorders associated with the skin.

URV Reference Number: 6-15040
Patent Information:
For Information, Contact:
Weimin Kaufman
Licensing Manager
University of Rochester
Lisa Delouise
Samreen Jatana
Brian Palmer